Limited-Time Offer for New Patients: Start GLP-1 Medical Weight Loss & Treat Stubborn Belly Fat with 4 Complimentary BTL Vanquish ME Treatments ($2,600 Value).
Skip to main content

Musculoskeletal and Tissue Healing with BPC 157

BPC-157

Musculoskeletal and Tissue Healing with BPC 157

Common injuries that occur while playing sports or engaging in daily activities involve damage to the body’s soft tissues. Soft tissues refer to one’s tendons, skeletal muscles, and ligaments. Damage to these musculoskeletal entities are typically caused by tears in these fibers during activity. The extent of recovery and recovery time of such injuries will vary depending on the specific injury.

BPC 157 is a compound that could potentially expedite the healing process for these types of injuries1. This article will discuss the details of BPC 157, its mechanism, and how it can support musculoskeletal and tissue healing.

What is BPC 157?

BPC 157, also referred to as Bepecin, PL 14736, and PL10, is a human gastric juice-derived protein. As a partial sequence of human gastric protein BPC, BPC 157 is a synthetic amino acid fragment. It is shown to demonstrate healing properties across several types of wounds, including wounds of the skin, gastric ulcers, cornea, and muscle. Notably, BPC 157 can also provide therapeutic benefit for damaged tendons, ligaments, skeletal muscles, and bones1,2.

How does BPC 157 help with tendon recovery?

A study evaluated the effect of BPC 157 on Achilles tendon injuries in rats. Compared to placebo control, BPC significantly bettered recovery parameters. At a biological level, mononuclear counts increased, granulocytes decreased, and fibroblast, reticulin, and collagen fiber formation increased. BPC 157-treated defects were also smaller in both depth and size. Likewise, BPC 157 helped re-establish full tendon integrity.

BPC 157 promotes healing via outgrowth and tendon fibroblast proliferation. Another study attempted to understand the mechanisms underlying BPC 157 in tendon recovery. Results indicated that BPC 157 increased the speed of tendon explant outgrowth. Additionally, BPC 157 accelerated tendon fibroblast spreading and in vitro migration and stimulated the FAX-paxillin pathway. BPC 157 also increased cell survival after H2O2 stress1,2.

How does BPC 157 help with skeletal muscle recovery?

BPC 157’s benefits extend beyond just ligament and tendon recovery, as it also demonstrates healing properties in musculoskeletal models. One study evaluated how BPC 157 affected quadricep transections in rats. BPC 157 treatment allowed for injury healing that was sustained over the course of 72 days1.

Another study evaluated how BPC 157 affected a gastrocnemius muscle complex injury in rats. The control group demonstrated minimal improvement and recovery. BPC 157, however, accelerated muscle recovery, accelerated functional restoration, and improved muscle recovery. These results were consistent across intraperitoneal and local administration3.

Conclusion

BPC 157 is a human gastric juice-derived protein that demonstrates robust effects on healing and recovery in rodent animal models. Several studies have evaluated the effects of BPC 157. Via several mechanisms, BPC 157 has demonstrated its ability to stimulate outgrowth and fibroblast proliferation, yielding clinical effects in healing tendons, ligaments, and muscles. However, caution should be taken when extrapolating these results to the clinic. Future studies are still needed evaluating the safety and efficacy of BPC 157 in humans.

 

References

  1. Gwyer, D., Wragg, N. M., & Wilson, S. L. (2019). Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research377(2), 153–159. https://doi.org/10.1007/s00441-019-03016-8
  2. Chang, C.-H., Tsai, W.-C., Lin, M.-S., Hsu, Y.-H., & Pang, J.-H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology110(3), 774–780. https://doi.org/10.1152/japplphysiol.00945.2010
  3. Pevec, D., Novinscak, T., Brcic, L., Sipos, K., Jukic, I., Staresinic, M., Mise, S., Brcic, I., Kolenc, D., Klicek, R., Banic, T., Sever, M., Kocijan, A., Berkopic, L., Radic, B., Buljat, G., Anic, T., Zoricic, I., Bojanic, I., … Sikiric, P. (2010). Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research16(3), BR81-88.
Author
David Bauder David J. Bauder, PA-C David Bauder, PA-C, is a certified physician assistant and the assistant medical director at Weight Loss and Vitality in Manassas and Alexandria, Virginia, Washington, DC; and Gaithersburg, MD. He enjoys helping patients optimize their physical and mental health to improve their overall well-being. He earned his physician assistant degree from the University of Texas Health Science Center at San Antonio. Afterward, he gained admission into the reputable graduate program for physician assistant studies at the University of Nebraska Health Science Center in Omaha. David has over 26 years of experience working as a physician assistant. He’s practiced in podiatry, family medicine, emergency medicine, general surgery, urgent care, and functional medicine.

You Might Also Enjoy...

TB-500 illustration showing muscle tissue repair, reduced inflammation, and improved blood flow in a flexed arm.

How TB-500 Promotes Recovery and Angiogenesis

TB-500 is a synthetic fragment of thymosin beta-4 associated with tissue repair and angiogenesis, but human evidence is limited, it is not FDA-approved, and its safety and effectiveness remain uncertain.
Retatrutide illustration showing digestive system and metabolic pathways related to weight loss and metabolism.

How Retatrutide Impacts Weight Loss and Metabolism

Retatrutide is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors that has shown significant weight loss and metabolic benefits in trials, but it is not yet FDA-approved and remains available only in clinical studies.
PT-141 illustration showing brain-driven sexual arousal and libido enhancement between two figures with neural activation.

How PT-141 Enhances Libido and Sexual Function

PT-141 (bremelanotide) is an FDA-approved melanocortin receptor agonist that enhances sexual desire in premenopausal women with HSDD, with strong clinical evidence, though use in men remains off-label and less established.